---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-002881"
form_type: "8-K"
ticker: "ZEOX"
cik: "0001557376"
company_name: "Zeo ScientifiX, Inc."
filed_at: "2026-03-31T23:59:59+00:00"
generated_at: "2026-05-15T08:09:29.449795+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ZEO named official regenerative medicine educational partner for A4M; Masterclass Apr 9

## Summary
- Role as official educational partner for regenerative medicine with A4M at Longevity SpringFest 2026.
- Will lead full-day Masterclass on Apr 9, 2026 in West Palm Beach for physicians.
- Access to A4M network of 26,000 physicians and practitioners from 120 nations.
- Longevity therapy market estimated at $29.9 billion (The Business Research Company, 2026).
- Partnership places ZEO alongside NASDAQ-listed Niagen Bioscience (NAGE) and InBody.

## SEC filing metadata
- accession: 0001829126-26-002881
- form_type: 8-K
- ticker: ZEOX
- cik: 0001557376
- company_name: Zeo ScientifiX, Inc.
- filed_at: 2026-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557376/000182912626002881/0001829126-26-002881-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557376/000182912626002881/zeoscientifix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-002881
- JSON: https://secwatch.observer/filing/0001829126-26-002881.json
- Plain text: https://secwatch.observer/filing/0001829126-26-002881.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.